Range
6.88 - 7.2
Vol / Avg.
820K/2.1M
Div / Yield
-
52 Wk
5.41 - 38.5
Mkt Cap
636.5M
Payout Ratio
-
Open
6.94
P/E
-
EPS
-0.53
Shares
91.7M
Outstanding
91.7M
Total Float
51.9M
Sector: Health Care.Industry: Biotechnology
Seres Therapeutics Inc is a microbiome therapeutics platform company operating in the United States. The company is engaged in developing biological drugs which are referred as ecobiotic microbiome therapeutics. The drugs discovered by the company are designed to restore health by repairing the function of a dysbiotic microbiome. The company focuses on implementing its microbiome therapeutics platform to develop ecobiotic microbiome therapeutics that treats dysbiosis in the colonic microbiome. SER-109, the company's product, is designed to prevent further recurrences of Clostridium difficile infection (CDI), a debilitating infection of the colon. In addition, the company is involved in developing SER-262, SER-287, and SER-401.

Earnings

see more
Q3 2021Est.ActualSurprise
EPS
(EXPECTED)2021-11-08
REV
Q2 2021Est.ActualSurprise
EPS-0.370-0.530 -0.1600
REV5.340M5.263M-77.000K

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target

Related Companies

TickerCompanyChg %Mkt Cap
MCRBSeres Therapeutics-2.12%636.5M

Seres Therapeutics Questions & Anwsers

Q

How do I buy Seres Therapeutics (MCRB) stock?

A

You can purchase shares of Seres Therapeutics (NASDAQ: MCRB) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are Seres Therapeutics's (MCRB) competitors?

Q

What is the target price for Seres Therapeutics (MCRB) stock?

A

The latest price target for Seres Therapeutics (NASDAQ: MCRB) was reported by Canaccord Genuity on July 23, 2021. The analyst firm set a price target for 29.00 expecting MCRB to rise to within 12 months (a possible 317.87% upside). 8 analyst firms have reported ratings in the last year.

Q

Current Stock Price for Seres Therapeutics (MCRB)?

A

The stock price for Seres Therapeutics (NASDAQ: MCRB) is $6.94 last updated Fri Sep 24 2021 20:00:02 GMT+0000 (Coordinated Universal Time).

Q

Does Seres Therapeutics (MCRB) pay a dividend?

A

There are no upcoming dividends for Seres Therapeutics.

Q

When is Seres Therapeutics (NASDAQ:MCRB) reporting earnings?

A
Seres Therapeutics’s Q3 earnings are confirmed for after-market on November 8, 2021.
Q

Is Seres Therapeutics (MCRB) going to split?

A

There is no upcoming split for Seres Therapeutics.

Q

What sector and industry does Seres Therapeutics (MCRB) operate in?

A

Seres Therapeutics is in the Consumer Discretionary sector and Multiline Retail industry. They are listed on the NASDAQ.